Two Sigma Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $59.4M | Buy |
64,550
+51,482
| +394% | +$52.2M | 0.05% | 430 |
|
|
2025
Q4 | $14M | Sell |
13,068
-187,838
| -93% | -$180M | 0.02% | 912 |
|
|
2025
Q3 | $153M | Buy |
200,906
+127,157
| +172% | +$94.6M | 0.23% | 126 |
|
|
2025
Q2 | $57.5M | Buy |
73,749
+58,016
| +369% | +$45.1M | 0.1% | 255 |
|
|
2025
Q1 | $13M | Sell |
15,733
-306,957
| -95% | -$255M | 0.03% | 662 |
|
|
2024
Q4 | $249M | Buy |
322,690
+122,954
| +62% | +$102M | 0.54% | 17 |
|
|
2024
Q3 | $177M | Sell |
199,736
-26,044
| -12% | -$23.4M | 0.39% | 57 |
|
|
2024
Q2 | $204M | Buy |
225,780
+154,159
| +215% | +$123M | 0.47% | 46 |
|
|
2024
Q1 | $55.7M | Sell |
71,621
-27,575
| -28% | -$19.6M | 0.13% | 194 |
|
|
2023
Q4 | $57.8M | Sell |
99,196
-333,538
| -77% | -$195M | 0.13% | 193 |
|
|
2023
Q3 | $232M | Buy |
+432,734
| New | +$223M | 0.63% | 16 |
|
|
2023
Q1 | – | Sell |
-294,302
| Closed | -$108M | – | 3094 |
|
|
2022
Q4 | $108M | Buy |
+294,302
| New | +$104M | 0.34% | 71 |
|
|
2022
Q2 | – | Sell |
-440,736
| Closed | -$126M | – | 2757 |
|
|
2022
Q1 | $126M | Buy |
440,736
+34,317
| +8% | +$8.83M | 0.37% | 58 |
|
|
2021
Q4 | $112M | Sell |
406,419
-590,491
| -59% | -$150M | 0.24% | 99 |
|
|
2021
Q3 | $230M | Buy |
+996,910
| New | +$246M | 0.51% | 6 |
|
|
2020
Q4 | – | Sell |
-130,213
| Closed | -$19.4M | – | 3568 |
|
|
2020
Q3 | $19.3M | Buy |
130,213
+124,275
| +2,093% | +$19.2M | 0.07% | 304 |
|
|
2020
Q2 | $975K | Sell |
5,938
-491,246
| -99% | -$75.4M | ﹤0.01% | 1554 |
|
|
2020
Q1 | $69M | Buy |
497,184
+39,140
| +9% | +$5.38M | 0.56% | 23 |
|
|
2019
Q4 | $60.2M | Buy |
458,044
+286,918
| +168% | +$33.3M | 0.18% | 128 |
|
|
2019
Q3 | $19.1M | Sell |
171,126
-101,211
| -37% | -$11.3M | 0.06% | 355 |
|
|
2019
Q2 | $30.2M | Buy |
+272,337
| New | +$32.1M | 0.1% | 250 |
|
|
2019
Q1 | – | Sell |
-26,947
| Closed | -$3.28M | – | 3285 |
|
|
2018
Q4 | $3.12M | Sell |
26,947
-1,175,303
| -98% | -$131M | 0.01% | 1023 |
|
|
2018
Q3 | $129M | Buy |
1,202,250
+611,453
| +103% | +$61.1M | 0.35% | 56 |
|
|
2018
Q2 | $50.4M | Sell |
590,797
-1,250,911
| -68% | -$103M | 0.15% | 175 |
|
|
2018
Q1 | $142M | Buy |
1,841,708
+1,668,278
| +962% | +$134M | 0.47% | 23 |
|
|
2017
Q4 | $14.6M | Buy |
+173,430
| New | +$14.8M | 0.05% | 458 |
|
|
2017
Q1 | – | Sell |
-116,791
| Closed | -$8.59M | – | 3128 |
|
|
2016
Q4 | $8.59M | Buy |
+116,791
| New | +$8.7M | 0.03% | 591 |
|
|
2016
Q3 | – | Sell |
-409,670
| Closed | -$32.8M | – | 3255 |
|
|
2016
Q2 | $32.3M | Sell |
409,670
-997,962
| -71% | -$75.1M | 0.14% | 173 |
|
|
2016
Q1 | $101M | Buy |
+1,407,632
| New | +$107M | 0.48% | 35 |
|
|
2015
Q4 | – | Sell |
-236,798
| Closed | -$19.7M | – | 2838 |
|
|
2015
Q3 | $19.8M | Buy |
236,798
+220,070
| +1,316% | +$18.6M | 0.1% | 226 |
|
|
2015
Q2 | $1.4M | Buy |
+16,728
| New | +$1.27M | 0.01% | 1432 |
|
|
2014
Q4 | – | Sell |
-45,559
| Closed | -$2.96M | – | 2309 |
|
|
2014
Q3 | $2.96M | Buy |
+45,559
| New | +$2.88M | 0.01% | 762 |
|
|
2014
Q1 | – | Sell |
-2,381,491
| Closed | -$121M | – | 2142 |
|
|
2013
Q4 | $121M | Buy |
2,381,491
+460,086
| +24% | +$23M | 0.67% | 14 |
|
|
2013
Q3 | $96.7M | Buy |
1,921,405
+331,423
| +21% | +$17.4M | 0.62% | 28 |
|
|
2013
Q2 | $78.1M | Buy |
+1,589,982
| New | +$86.5M | 0.55% | 25 |
|
Other funds holding LLY
VCM
VPM
Two Sigma Investments's LLY Position: Q1 2026 in Review
Two Sigma Investments increased its Eli Lilly (LLY) stake by 394% in Q1 2026, buying an estimated $52.2M and bringing the position to 64,550 shares worth $59.4M. The position accounts for 0.05% of the portfolio, ranked #430.
Two Sigma Investments first reported a position in LLY in Q2 2013 and has held it in 35 quarters since. The position peaked at $249M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Two Sigma Investments held 64,550 shares of Eli Lilly worth $59.4M as of Q1 2026.
- Two Sigma Investments bought 51,482 Eli Lilly shares in Q1 2026, an estimated $52.2M.
- Eli Lilly made up 0.05% of Two Sigma Investments's portfolio in Q1 2026, its #430 holding.
- Two Sigma Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 35 quarters since.
- Two Sigma Investments's Eli Lilly position peaked at $249M in Q4 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.